Therapeutic effect and mechanism of combined use of FGF21 and insulin on diabetic nephropathy
- PMID: 34695409
- DOI: 10.1016/j.abb.2021.109063
Therapeutic effect and mechanism of combined use of FGF21 and insulin on diabetic nephropathy
Abstract
Although FGF21 ameliorates diabetic nephropathy (DN), the efficacy is not satisfactory. Studies demonstrate that FGF21 combined with Insulin exhibits reciprocal sensitization on glucose and lipid metabolism in mice with type 2 diabetes. However, therapeutic effect of combined use of FGF21 and Insulin on DN has not been reported. Therefore, this study explored therapeutic effect and mechanism of combined use of FGF21 and Insulin on DN. Our results showed that compared with Insulin or FGF21 alone, FGF21 combined with Insulin further ameliorated blood glucose, HbAlc, OGTT, renal function, liver function, blood lipid, histopathological changes, oxidative stress and AGEs in the mice of DN (BKS-Leprem2Cd479/Gpt). Moreover, FGF21 combined with Insulin further reduced expressions of IL-1β, IL-6, TNF-α via promoting M1 type macrophage into M2 type macrophage. Results of real-time PCR and Western blot showed that FGF21 combined with Insulin upregulated the expressions of autophagy related genes LC3-Ⅱ and BCL-1. Mesangial cells play an important role in the pathological changes of DN mice. However, the effect of FGF21 on mesangial cells has not been reported. In this study, d-glucose was used in high glucose (HG) model in mesangial cells. The results showed that FGF21 significantly reduced the levels of OS, AGEs and cell overproliferation. Meanwhile, FGF21 significantly ameliorated autophagy level via upregulating the phosphorylation of AMPK and downregulating phosphorylation of mTOR. These effects were reversed in siRNA-β-klotho transfected mesangial cells. In conclusion, our results demonstrate that combination FGF21 with Insulin exhibits a better therapeutic effect on DN compared with FGF21 or Insulin alone. This study provides a theoretical basis for combined used of FGF21 and Insulin as a new treatment for DN and further provides theoretical support for application of FGF21 in treatment of DN.
Keywords: AMPK/mTOR; Autophagy; DN; FGF21; Insulin.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.Endocrinology. 2013 Sep;154(9):3366-76. doi: 10.1210/en.2012-2276. Epub 2013 Jul 3. Endocrinology. 2013. PMID: 23825123
-
Study on the inhibitive effect of Catalpol on diabetic nephropathy.Life Sci. 2020 Sep 15;257:118120. doi: 10.1016/j.lfs.2020.118120. Epub 2020 Jul 18. Life Sci. 2020. PMID: 32693244
-
Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model.Am J Physiol Endocrinol Metab. 2015 Jul 1;309(1):E45-54. doi: 10.1152/ajpendo.00026.2015. Epub 2015 May 12. Am J Physiol Endocrinol Metab. 2015. PMID: 25968574 Free PMC article.
-
The emerging role of fibroblast growth factor 21 in diabetic nephropathy.J Recept Signal Transduct Res. 2016 Dec;36(6):586-592. doi: 10.3109/10799893.2016.1147582. Epub 2016 Feb 26. J Recept Signal Transduct Res. 2016. PMID: 26915669 Review.
-
Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.Acta Pharm Sin B. 2021 Sep;11(9):2749-2767. doi: 10.1016/j.apsb.2020.12.020. Epub 2021 Feb 2. Acta Pharm Sin B. 2021. PMID: 34589395 Free PMC article. Review.
Cited by
-
Critical role of FGF21 in diabetic kidney disease: from energy metabolism to innate immunity.Front Immunol. 2024 Jan 19;15:1333429. doi: 10.3389/fimmu.2024.1333429. eCollection 2024. Front Immunol. 2024. PMID: 38312833 Free PMC article. Review.
-
FGF21-mediated autophagy: Remodeling the homeostasis in response to stress in liver diseases.Genes Dis. 2023 Jul 13;11(3):101027. doi: 10.1016/j.gendis.2023.05.019. eCollection 2024 May. Genes Dis. 2023. PMID: 38292187 Free PMC article. Review.
-
Fibroblast Growth Factor 21: A Fascinating Perspective on the Regulation of Muscle Metabolism.Int J Mol Sci. 2023 Nov 29;24(23):16951. doi: 10.3390/ijms242316951. Int J Mol Sci. 2023. PMID: 38069273 Free PMC article. Review.
-
Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine.Int J Biol Sci. 2023 Jan 1;19(1):66-88. doi: 10.7150/ijbs.73936. eCollection 2023. Int J Biol Sci. 2023. PMID: 36594101 Free PMC article. Review.
-
Myokines: Novel therapeutic targets for diabetic nephropathy.Front Endocrinol (Lausanne). 2022 Oct 25;13:1014581. doi: 10.3389/fendo.2022.1014581. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36387916 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
